PMCTPharmaCountry
    Startseite

Regulatorische Updates

Regulatorische Entwicklungen von FDA, EMA, TGA und weltweit

#Pharmobedient ×

UPDATED
Regulatorische Updates
9. Sept. 2026•1 Min. Lesezeit
FOSPHENYTOIN SODIUM (ANDA078736) FDA Approval
FDA approves the original ANDA and multiple labeling supplements for fosphenytoin sodium injection (product 001) by Pharmobedient.
UPDATED
Regulatorische Updates
24. Aug. 2026•1 Min. Lesezeit
FDA Approves ANDA078070 for Valacyclovir Hydrochloride Tablets by Pharmobedient
The FDA approved application ANDA078070 submitted by Pharmobedient for oral valacyclovir hydrochloride tablets (500 mg and 1 g equivalents). Both products are listed as discontinued.